Authors: Stier, DM Gause, D Joseph, WS Schein, JR Broering, JM Warolin, KL Doyle, JJ

Citation: Dm. Stier et al., Patient satisfaction with oral versus nonoral therapeutic approaches in onychomycosis, J AM POD M, 91(10), 2001, pp. 521-527

Authors: Saydah, SH Miret, M Sung, J Varas, C Gause, D Brancati, FL

Citation: Sh. Saydah et al., Postchallenge hyperglycemia and mortality in a national sample of US adults, DIABET CARE, 24(8), 2001, pp. 1397-1402

Authors: Jacobson, TA Griffiths, GG Varas, C Gause, D Sung, JCY Ballantyne, CM

Citation: Ta. Jacobson et al., Impact of evidence-based "clinical judgment" on the number of American adults requiring lipid-lowering therapy based on updated NHANES III data, ARCH IN MED, 160(9), 2000, pp. 1361-1369

Authors: Jacobson, TA Griffiths, GG Varas, C Gause, D Sung, JCY Ballantyne, CM

Citation: Ta. Jacobson et al., Impact of evidence-based 'clinical judgment' on the number of American adults requiring lipid-lowering therapy based on updated NHANES III data (vol 160, pg 1361, 2000), ARCH IN MED, 160(15), 2000, pp. 2333-2333

Authors: Lubeck, DP Gause, D Schein, JR Prebil, LE Potter, LP

Citation: Dp. Lubeck et al., A health-related quality of life measure for use in patients with onychomycosis: a validation study, QUAL LIFE R, 8(1-2), 1999, pp. 121-129